Table 1. Summary of CSF analysis of genetic prion disease cases.
GSS | FFI | g CJD | ||
P102L | D178N | E200K | V203I | |
Number | 20 | 12 | 22 | 2 |
Age (average year) | 55.5±4.45 | 55.8±13.7 | 62.7±9.43 | 73 |
Sex (m∶f) | 1∶3 | 3∶1 | 1∶1 | 2∶0 |
positive patients/total (%) | ||||
[95% CI*] | ||||
4/20 | 1/12 | 19/22 | 1/2 | |
t-tau protein | (20%) | (8.3%) | (86.3%) | (50%) |
[2.6–37.4%] | [0–25.4%] | [70.2–100%] | ||
4/20 | 1/12 | 18/22 | 1/2 | |
14-3-3 protein | (20%) | (8.3%) | (81.8%) | (50%) |
[2.6–37.4%] | [0–25.4%] | [67.4–96.2%] | ||
18/20 | 10/12 | 18/22 | 2/2 | |
RT-QUIC | (90%) | (83.3%) | (81.8%) | (100%) |
[76.5–100%] | [70.2–100%] | [67.4–96.2%] |
The 95% confidence interval [CI] was calculated using the adjusted Wald test, and was expressed only in groups of more than seven cases.